The CD47/signal-regulatory protein α (SIRPα) complex is key macrophage-related immune check point, which has been increasingly recognized as a promising therapeutic target in DDLPS [23, 24]. The gene discussed is SIRPA; the disease is dedifferentiated liposarcoma.